Electromed, Inc. (ELMD)

Market Cap	167.81M
Revenue (ttm)	61.44M
Net Income (ttm)	7.16M
Shares Out	8.39M
EPS (ttm)	0.79
PE Ratio	25.36
Forward PE	22.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,224
Open	20.30
Previous Close	20.51
Day's Range	20.00 - 21.20
52-Week Range	13.74 - 35.56
Beta	0.41
Analysts	Strong Buy
Price Target	38.00 (+89.91%)
Earnings Date	Aug 26, 2025

About ELMD

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway Syst...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 13, 2010
• Employees: 174
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: ELMD
• Website: https://smartvest.com

Financial Performance

In 2024, Electromed's revenue was $54.72 million, an increase of 13.83% compared to the previous year's $48.07 million. Earnings were $5.15 million, an increase of 62.67%.

Analyst Summary

According to one analyst, the rating for ELMD stock is "Strong Buy" and the 12-month stock price target is $38.0.

Price Target

$38.0

(89.91% upside)

Analyst Consensus: Strong Buy